411 related articles for article (PubMed ID: 16472520)
1. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence.
Dorella FA; Pacheco LG; Oliveira SC; Miyoshi A; Azevedo V
Vet Res; 2006; 37(2):201-18. PubMed ID: 16472520
[TBL] [Abstract][Full Text] [Related]
2. Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development.
Dorella FA; Pacheco LG; Seyffert N; Portela RW; Meyer R; Miyoshi A; Azevedo V
Expert Rev Vaccines; 2009 Feb; 8(2):205-13. PubMed ID: 19196200
[TBL] [Abstract][Full Text] [Related]
3. A description of genes of Corynebacterium pseudotuberculosis useful in diagnostics and vaccine applications.
D'Afonseca V; Moraes PM; Dorella FA; Pacheco LG; Meyer R; Portela RW; Miyoshi A; Azevedo V
Genet Mol Res; 2008 Mar; 7(1):252-60. PubMed ID: 18551390
[TBL] [Abstract][Full Text] [Related]
4. An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.
Ribeiro D; Rocha Fde S; Leite KM; Soares Sde C; Silva A; Portela RW; Meyer R; Miyoshi A; Oliveira SC; Azevedo V; Dorella FA
Vet Res; 2014 Mar; 45(1):28. PubMed ID: 24597857
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene expression in sheep following experimental infection with various strains of Corynebacterium pseudotuberculosis differing in virulence.
Pépin M; Seow HF; Corner L; Rothel JS; Hodgson AL; Wood PR
Vet Res; 1997; 28(2):149-63. PubMed ID: 9112737
[TBL] [Abstract][Full Text] [Related]
6. Identification of new Corynebacterium pseudotuberculosis antigens by immunoscreening of gene expression library.
Galvão CE; Fragoso SP; de Oliveira CE; Forner O; Pereira RRB; Soares CO; Rosinha GMS
BMC Microbiol; 2017 Sep; 17(1):202. PubMed ID: 28934943
[TBL] [Abstract][Full Text] [Related]
7. Isolation and molecular characterization of Corynebacterium pseudotuberculosis from sheep and goats in Mexico.
Guerrero JAV; de Oca Jiménez RM; Acosta Dibarrat J; León FH; Morales-Erasto V; Salazar HGM
Microb Pathog; 2018 Apr; 117():304-309. PubMed ID: 29474828
[TBL] [Abstract][Full Text] [Related]
8. Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production.
Soares SC; Trost E; Ramos RT; Carneiro AR; Santos AR; Pinto AC; Barbosa E; Aburjaile F; Ali A; Diniz CA; Hassan SS; Fiaux K; Guimarães LC; Bakhtiar SM; Pereira U; Almeida SS; Abreu VA; Rocha FS; Dorella FA; Miyoshi A; Silva A; Azevedo V; Tauch A
J Biotechnol; 2013 Aug; 167(2):135-41. PubMed ID: 23201561
[TBL] [Abstract][Full Text] [Related]
9. Identification and role in virulence of putative iron acquisition genes from Corynebacterium pseudotuberculosis.
Billington SJ; Esmay PA; Songer JG; Jost BH
FEMS Microbiol Lett; 2002 Feb; 208(1):41-5. PubMed ID: 11934492
[TBL] [Abstract][Full Text] [Related]
10. Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene.
Tachedjian M; Krywult J; Moore RJ; Hodgson AL
Vaccine; 1995 Dec; 13(18):1785-92. PubMed ID: 8701594
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of caseous lymphadenitis in sheep from Patagonia].
Estevao Belchior S; Gallardo A; Abalos A; Díaz Y; Alvarez L; Callejo R; Prieto M; Jodor N; Jensen O
Rev Argent Microbiol; 2007; 39(1):44-6. PubMed ID: 17593581
[TBL] [Abstract][Full Text] [Related]
12. A shift in the virulence potential of Corynebacterium pseudotuberculosis biovar ovis after passage in a murine host demonstrated through comparative proteomics.
Silva WM; Dorella FA; Soares SC; Souza GH; Castro TL; Seyffert N; Figueiredo H; Miyoshi A; Le Loir Y; Silva A; Azevedo V
BMC Microbiol; 2017 Mar; 17(1):55. PubMed ID: 28327085
[TBL] [Abstract][Full Text] [Related]
13. Survey of genome organization and gene content of Corynebacterium pseudotuberculosis.
D'Afonseca V; Prosdocimi F; Dorella FA; Pacheco LG; Moraes PM; Pena I; Ortega JM; Teixeira S; Oliveira SC; Coser EM; Oliveira LM; Corrêa de Oliveira G; Meyer R; Miyoshi A; Azevedo V
Microbiol Res; 2010 May; 165(4):312-20. PubMed ID: 19720513
[TBL] [Abstract][Full Text] [Related]
14. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines.
Stanford K; Brogden KA; McClelland LA; Kozub GC; Audibert F
Can J Vet Res; 1998 Jan; 62(1):38-43. PubMed ID: 9442938
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Identification of Corynebacterium pseudotuberculosis from sheep by PCR-restriction analysis using the RNA polymerase β-subunit gene (rpoB).
Pavan ME; Robles C; Cairó FM; Marcellino R; Pettinari MJ
Res Vet Sci; 2012 Apr; 92(2):202-6. PubMed ID: 21419467
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.
de Pinho RB; de Oliveira Silva MT; Bezerra FSB; Borsuk S
Appl Microbiol Biotechnol; 2021 Mar; 105(6):2287-2296. PubMed ID: 33651132
[TBL] [Abstract][Full Text] [Related]
18. Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.
Silva JW; Droppa-Almeida D; Borsuk S; Azevedo V; Portela RW; Miyoshi A; Rocha FS; Dorella FA; Vivas WL; Padilha FF; Hernández-Macedo ML; Lima-Verde IB
BMC Vet Res; 2014 Dec; 10():965. PubMed ID: 25527190
[TBL] [Abstract][Full Text] [Related]
19. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components.
Braga WU
Vet Microbiol; 2007 Jan; 119(2-4):297-303. PubMed ID: 16982160
[TBL] [Abstract][Full Text] [Related]
20. Acquired immunity after primary caseous lymphadenitis in sheep.
Pépin M; Pardon P; Marly J; Lantier F; Arrigo JL
Am J Vet Res; 1993 Jun; 54(6):873-7. PubMed ID: 8323055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
